Genomic and human papillomavirus profiling of an oral cancer cohort identifies TP53 as a predictor of overall survival.
Neil MundiStephenie D ProkopecFarhad GhasemiAndrew WarnerKrupal PatelDanielle MacNeilChristopher HowlettWilliam StechoPaul PlantingaNicole PintoKara M RuicciMohammed Imran KhanMyung Woul HanJohn YooKevin FungAxel SahovalerDavid A PalmaEric WinquistJoe S MymrykJohn W BarrettPaul C BoutrosAnthony C NicholsPublished in: Cancers of the head & neck (2019)
Mutations in TP53 were associated with poor patient survival. Expanding our sample size may identify further predictors of outcome to direct customized cancer care.